All Products

A catalogue shorthand entry commonly used for cabergoline, a prescription dopamine-agonist medicine. The supplied pack label is required to confirm identity and strength.

A supplier-style catalogue name. The name alone does not establish the active ingredient, formulation or regulatory status; confirm those details from the original packaging and documentation.

NovoRapid is a prescription rapid-acting insulin-aspart presentation. Insulin errors can cause severe hypoglycaemia, so this entry is displayed for catalogue identification only.

Lantus is a prescription long-acting insulin-glargine presentation. Insulin errors can cause severe hypoglycaemia, so this entry is displayed for catalogue identification only.

T3 is catalogue shorthand commonly used for liothyronine, a prescription thyroid-hormone medicine. The original label must be checked for the precise ingredient and strength.

T4 is catalogue shorthand commonly used for levothyroxine, a prescription thyroid-hormone medicine. The original label must be checked for the precise ingredient and strength.

A catalogue shorthand entry commonly associated with clenbuterol. It is not licensed for human use in the UK and may carry serious cardiovascular risks.

Clomid is a trade name associated with clomifene, a prescription selective oestrogen-receptor modulator. This is an identity reference, not treatment guidance.

Arimidex is a trade name for anastrozole, a prescription aromatase inhibitor. This is an identity reference, not treatment guidance.

HCG means human chorionic gonadotrophin, a hormone used in specific licensed medical contexts. The vial strength is shown for catalogue identification only.

HMG means human menopausal gonadotrophin, a prescription fertility hormone preparation. The vial strength is shown for catalogue identification only.

Nolvadex is a trade name for tamoxifen, a prescription selective oestrogen-receptor modulator. This is an identity reference, not treatment guidance.

Letro is catalogue shorthand commonly used for letrozole, a prescription aromatase inhibitor. This is an identity reference, not treatment guidance.

A branded catalogue entry labelled as human growth hormone. The brand name and IU total do not independently establish identity, purity or authenticity.

Modafinil is a prescription wakefulness-promoting medicine. This entry records the stated pack format for catalogue reference only.

Metformin is a prescription medicine used in diabetes care and some other clinician-directed contexts. This entry records the stated pack format for catalogue reference only.

Aromasin is a trade name for exemestane, a prescription aromatase inhibitor. The exact strength must be confirmed from the original packaging.

Accutane is a trade name associated with isotretinoin, a prescription retinoid requiring strict clinical monitoring. This is an identity reference only.

A supplier-style catalogue entry associated with sildenafil tablets. The original packaging must be checked carefully because the catalogue name alone does not confirm identity or authorised status.

A supplier-style catalogue entry associated with sildenafil tablets. The original packaging must be checked carefully because the catalogue name alone does not confirm identity or authorised status.

A supplier-style catalogue entry associated with tadalafil tablets. The original packaging must be checked carefully because the catalogue name alone does not confirm identity or authorised status.

A supplier-style liquid product name. It does not identify the active ingredients, concentration or formulation; consult the complete original label and documentation.

A trade-style product name commonly associated with sildenafil-containing products. It is not an authorised UK medicine, and the name alone does not establish identity or quality.

A vitamin B12 catalogue entry. The exact cobalamin form, concentration and presentation must be confirmed from the original packaging; the catalogue name alone is insufficient.

A 10 mL multi-dose injectable vial labelled at a total concentration of 400 mg/mL. “Test 400” is a supplier blend name rather than a standard generic medicine name, so the testosterone esters and their individual amounts must be confirmed from the vial or box label.

A 10 mL multi-dose injectable vial labelled as testosterone enanthate at 300 mg/mL. Testosterone enanthate is the heptanoate ester of testosterone.

A 10 mL multi-dose injectable vial labelled as testosterone cypionate at 250 mg/mL. Testosterone cypionate is an esterified form of testosterone.

A 10 mL multi-dose injectable vial labelled as a multi-ester testosterone blend with a total ester concentration of 300 mg/mL. This is not the same stated strength as licensed Sustanon 250; the precise esters and their individual amounts are manufacturer-specific and should be checked on the product label.

A 10 mL multi-dose injectable vial labelled as testosterone propionate at 120 mg/mL. Testosterone propionate is the propionate ester of testosterone.

A 10 mL multi-dose injectable vial labelled as trenbolone acetate at 120 mg/mL. Trenbolone acetate is the acetate ester of trenbolone.

A 10 mL multi-dose injectable vial labelled as trenbolone enanthate at 250 mg/mL. The enanthate name identifies the heptanoate ester attached to trenbolone.

A 10 mL multi-dose injectable vial labelled as trenbolone hexahydrobenzylcarbonate at 75 mg/mL, often shortened to trenbolone hex or tren hex.

A 10 mL multi-dose injectable vial labelled as a 200 mg/mL blend. “RIP Blend” is not a standard generic drug name and does not, by itself, establish the active ingredients or their ratios; those details must be taken from the vial or box label.

A 10 mL multi-dose injectable vial labelled as nandrolone decanoate at 330 mg/mL. “Deca” is commonly used as shorthand for the decanoate ester of nandrolone.

A 10 mL multi-dose injectable vial labelled as nandrolone phenylpropionate at 150 mg/mL. NPP is the common abbreviation for this nandrolone ester.

A 10 mL multi-dose injectable vial labelled as boldenone undecylenate at 350 mg/mL. “Equipoise” is a trade-style name associated with the undecylenate ester of boldenone.

A 10 mL multi-dose injectable vial labelled at 50 mg/mL. DHB is commonly used as shorthand for dihydroboldenone, also called 1-testosterone, but the abbreviation alone does not confirm which ester is present; check the product label for the complete chemical form.

A 10 mL multi-dose injectable vial labelled as drostanolone propionate at 150 mg/mL. “Mast” is catalogue shorthand for drostanolone (also spelled dromostanolone), with the propionate ester specified here.

A 10 mL multi-dose injectable vial labelled as drostanolone enanthate at 250 mg/mL. “Mast” is catalogue shorthand for drostanolone, with the enanthate ester specified here.

A 10 mL multi-dose injectable vial labelled as methenolone enanthate at 150 mg/mL. Injectable Primobolan-style products are associated with the enanthate ester; the vial label remains the definitive identification for this catalogue item.

A 10 mL multi-dose injectable vial labelled as trestolone acetate at 50 mg/mL. Trestolone is also known in research literature as 7α-methyl-19-nortestosterone (MENT); this entry specifies its acetate ester.

A 10 mL multi-dose injectable vial labelled as a low-concentration testosterone preparation at 10 mg/mL. “Femtest” is a supplier product name and does not identify a standard testosterone ester, so the exact ester and carrier should be confirmed from the vial or box label.

A pack of 50 oral tablets, each labelled to contain 20 mg of methandienone (also called methandrostenolone). “Dbol” is the common shorthand derived from the former Dianabol trade name.

A pack of 50 oral tablets, each labelled to contain 50 mg of methandienone (also called methandrostenolone). “Dbol” is the common shorthand derived from the former Dianabol trade name.

A pack of 50 oral tablets, each labelled to contain 50 mg of oxymetholone, an orally active anabolic-androgenic steroid.

A pack of 50 oral tablets, each labelled to contain 20 mg of oxandrolone. “Anavar” is a trade name commonly used as shorthand for oxandrolone.

A pack of 50 oral tablets, each labelled to contain 50 mg of oxandrolone. “Anavar” is a trade name commonly used as shorthand for oxandrolone.

A pack of 50 oral tablets, each labelled to contain 20 mg of stanozolol. “Winny” is informal catalogue shorthand associated with the Winstrol trade name.

A pack of 50 oral tablets, each labelled to contain 50 mg of stanozolol. “Winny” is informal catalogue shorthand associated with the Winstrol trade name.

A pack of 50 oral tablets, each labelled to contain 20 mg of chlorodehydromethyltestosterone, also known as dehydrochloromethyltestosterone or Oral Turinabol.

A pack of 50 oral tablets, each labelled to contain 20 mg of mesterolone. Proviron is a trade name for mesterolone.

A pack of 50 oral tablets, each labelled to contain 5 mg of melatonin, the hormone N-acetyl-5-methoxytryptamine. This item is not an anabolic steroid.

A pack of 50 oral tablets, each labelled to contain 20 mg of methasterone, also called methyldrostanolone. Superdrol is a trade-style name for this orally active anabolic-androgenic steroid.

A pack of 50 oral tablets, each labelled to contain 40 mg of telmisartan, an angiotensin II receptor blocker. This item is a prescription blood-pressure medicine, not an anabolic steroid.

A pack of 50 oral tablets, each labelled to contain 5 mg of yohimbine, an indole alkaloid and alpha-2 adrenergic receptor antagonist. This item is not an anabolic steroid.

A pack of 50 oral tablets, each labelled to contain 10 mg of fluoxymesterone. “Halo” is informal shorthand associated with the Halotestin trade name.

A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research. Studies consider cell migration, inflammatory signalling and wound-repair pathways, but the combined ‘Wolverine’ format is not an approved clinical formulation.

A three-amino-acid fragment of alpha-MSH investigated for anti-inflammatory signalling. Laboratory and animal studies explore epithelial barriers, skin and gastrointestinal models; effects in people have not been established.

A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology. Studies explore collagen, elastin, tissue remodelling and hair-follicle pathways, with evidence varying by formulation and use.

A synthetic tetrapeptide explored in research on cellular ageing, oxidative stress and circadian biology. Evidence is limited and does not establish strong longevity claims or an approved anti-ageing use.

A synthetic ACTH-derived peptide investigated in neurological, cognitive and stress-response research. Published work is limited, and advertised focus or mood effects should not be treated as established clinical outcomes.

A synthetic tuftsin-derived peptide studied in anxiety, stress, cognition and neuroimmune signalling models. The evidence base remains limited and does not establish guaranteed mood or cognitive effects.

A modified, longer-acting analogue of insulin-like growth factor 1 used to investigate IGF-1 receptor signalling. Laboratory research considers cell growth, protein synthesis and metabolic pathways; it is a research reagent rather than an approved medicine.

A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation. Research explores mitochondrial function, insulin sensitivity and exercise-response pathways, although most intervention evidence remains preclinical.

KLOW is a catalogue name commonly used for a four-component research blend of GHK-Cu, BPC-157, TB-500 and KPV. It brings together materials investigated in skin and connective-tissue biology, cell migration and inflammatory signalling. Check the product label and batch documentation for the precise formulation of the supplied pen.

Melanotan II (MT2) is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), a signal involved in skin pigmentation. It activates melanocortin receptors and is studied for its ability to stimulate melanin, the pigment responsible for skin colour and tanning. A small early human study observed increased pigmentation, but this does not establish long-term safety or validate this pen formulation. Reported effects include nausea, flushing and changes in moles or freckles. This entry identifies the labelled 10 mg pen format. For research purposes only; not an approved tanning treatment or a substitute for sun protection.

A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology. Studies explore collagen, elastin, tissue remodelling and hair-follicle pathways, with evidence varying by formulation and use.

A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research. Studies consider cell migration, inflammatory signalling and wound-repair pathways, but the combined ‘Wolverine’ format is not an approved clinical formulation.

NAD+ (nicotinamide adenine dinucleotide) is a cellular coenzyme involved in oxidation–reduction reactions and energy metabolism. It is not a peptide. The listed strength and presentation identify the catalogue format, not proven bioavailability or an established anti-ageing effect.

A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation. Research explores mitochondrial function, insulin sensitivity and exercise-response pathways, although most intervention evidence remains preclinical.

An investigational triple receptor agonist designed to act on GLP-1, GIP and glucagon pathways. Researchers are studying how this combined signalling may affect appetite, glucose regulation, energy balance and body composition. It is not currently an approved UK medicine.

An investigational triple receptor agonist designed to act on GLP-1, GIP and glucagon pathways. Researchers are studying how this combined signalling may affect appetite, glucose regulation, energy balance and body composition. It is not currently an approved UK medicine.

A dual GIP and GLP-1 receptor agonist associated with appetite, insulin and glucose-regulation pathways. Authorised prescription versions have established clinical uses, but unlicensed research material is not equivalent to an approved medicine.